Contrast Enhanced-Magnetic Resonance Imaging as a Surrogate to Map Verteporfin Delivery in Photodynamic Therapy

Journal of Biomedical Optics- United States

doi 10.1117/1.jbo.18.12.120504

Full Text

Abstract

Available in

Date

Authors

Publisher

SPIE-Intl Soc Optical Eng

Related search

Contrast Agents in Dynamic Contrast-Enhanced Magnetic Resonance Imaging

Oncotarget
Oncology
2017English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of Ocular Melanoma as a Tool to Predict Metastatic Potential

Journal of Computer Assisted Tomography
Nuclear MedicineRadiologyImaging
2017English

Delayed Contrast-Enhanced Magnetic Resonance Imaging in Pulmonary Arterial Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging of OATP Dysfunction in Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

Contrast-Enhanced Magnetic Resonance Angiography

Acta Radiologica
Nuclear MedicineRadiologyUltrasound TechnologyRadiologicalImagingMedicine
2003English

Image-Guided Focused-Ultrasound CNS Molecular Delivery: An Implementation via Dynamic Contrast-Enhanced Magnetic-Resonance Imaging

Scientific Reports
Multidisciplinary
2018English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Pharmacokinetic Models in Prostate Cancer

European Radiology
MedicineNuclear MedicineRadiologyImaging
2010English

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Biomarker for Prediction of Radiation-Induced Neurocognitive Dysfunction

Clinical Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy